This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Phase Pharmaceuticals LLC. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: G Lynn Howard: Innovator in Anaphylaxis Treatment
Introduction
G Lynn Howard is a notable inventor based in Dallas, TX (US), recognized for her contributions to medical innovations. With a focus on improving treatment methods for critical health conditions, she has been awarded 2 patents that showcase her dedication to advancing healthcare solutions.
Latest Patents
One of her significant inventions is the sublingual epinephrine tablet, which provides a novel approach to treating anaphylaxis. This patent outlines methods for using these tablets not only for anaphylaxis but also for concomitant therapy during cardiac events, treating hypoglycemia, and as prophylaxis for immunotherapy. The dual application of this invention highlights its potential impact on patient care and emergency response.
Career Highlights
G Lynn Howard has made substantial strides in her career, particularly through her work at Phase Pharmaceuticals LLC. Her innovative spirit and commitment to healthcare have positioned her as a key player in the pharmaceutical industry.
Collaborations
She collaborates with talented professionals, including Nicholas J Farina and Edward J Walters, who contribute to her projects and enhance the development of her inventions.
Conclusion
G Lynn Howard's work exemplifies the intersection of innovation and healthcare, particularly through her development of sublingual epinephrine tablets. Her contributions are paving the way for improved treatment options for patients facing life-threatening conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile